Lupin Ltd


BSE: 500257 | NSE: LUPIN | ISIN: INE326A01037 
Market Cap: [Rs.Cr.] 34,418 | Face Value: [Rs.] 2
Industry: Pharmaceuticals - Indian - Bulk Drugs

 Discuss this stock

Board Meet

08-May-13 
Lupin Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 08, 2013, inter alia, to consider stand-alone and consolidated annual audited financial results for the year ended March 31, 2013 and recommend dividend, if any. Lupin Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 08, 2013, inter alia, has recommended dividend @ 200% i.e. Rs. 4/- per equity shares of the face value of Rs. 2/- each for the year ended March 31, 2013. Lupin Ltd has informed BSE thatthe Board of Directors of the Company at its meeting held on May 08, 2013, has approved the elevation of Dr. Kamal K. Sharma as Vice Chairman, Mrs. Vinita Gupta as CEO and Mr. Nilesh Gupta as Managing Director, effective September 1, 2013, on such terms and conditions as may be finalised and subject to necessary approvals as may be required. In this regard, the Company has submitted to a copy of Press Release titled 'Lupin announces Executive Board Leadership Changes'. (As per BSE Announcement Dated on 08.05.2013) 
31-Jan-13 
Lupin Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 31, 2013, inter alia, to consider and take on record unaudited financial results for the quarter ended December 31, 2012 (Q3). 
23-Oct-12 
Lupin Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 23, 2012, inter alia, to consider and take on record unaudited financial results for the quarter ended September 30, 2012 (Q2). Lupin Ltd has informed BSE that at the meeting of the Board of Directors held on October 23, 2012, the Board : 1. Appointed Mr. Dileep C. Choksi as Additional Director. 2. Appointed Mr. Dileep C. Choksi as Member of the Audit Committee. 3. Appointed Dr. Vijay Kelkar as Chairman of the Investors' Grievances Committee and 4. Noted and took note of resignation of Mr. D. K. Contractor from the directorship of the Company on health grounds. (As per BSE Announcement Dated on 23.10.2012)  
24-Jul-12 
Lupin Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 24, 2012, inter alia, to consider and take on record the unaudited financial results for the quarter ended June 30, 2012 (Q1). 
10-May-12 
Lupin Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 10, 2012, inter alia, to consider stand-alone and consolidated annual audited financial results for the year ended March 31, 2012 and recommend dividend, if any. Lupin Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 10, 2012, inter alia, has recommended dividend @ 160% i.e. Rs. 3.20 per equity share of the face value of Rs. 2/- each for the year ended March 31, 2012. (As Per BSE Announcement Dated on 10.05.2012) 

AGM

24-Jul-12
Lupin Limited has informed the Exchange that the Annual General Meeting of the Company will be held on July 24,2012.Further the Board of Directors have decided to close the Register of Members and Share Transfer Register from July 17,2012 to July 24,2012 (both days inclusive) for the purpose of Annual General Meeting and Dividend. Lupin Ltd has informed BSE that the 30th Annual General Meeting (AGM) of the Company will be held on July 24, 2012. (As Per BSE ANnouncement Website Dated on 09/07/2012) Lupin Limited has informed the Exchange regarding the Proceeding of the Annual General Meeting held on July 24,2012 and details of Voting Results pursuant to Clause 35A of the Listing Agreement. (As Per NSE Bulletin Dated on 27.07.2012) Lupin Ltd has informed BSE that the 30th Annual General Meeting (AGM) of the Company was held on July 24, 2012, under Clause 35A. (For more details kindly refer Corporate Announcements on www.bseindia.com). (As Per BSE Announcement Dated on 28.07.2012) 
27-Jul-11
Lupin Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 20, 2011 to July 27, 2011 (both days inclusive) for the purpose of Payment of Dividend & 29th Annual General Meeting (AGM) of the Company to be held on July 27, 2011. Lupin Limited has submitted to the Exchange a copy of the Minutes of the Annual General Meeting of the Company held on July 27, 2011. (As Per NSE Bulletin Dated on 10/08/2011) Lupin Ltd has informed BSE that the members at the 29th Annual General Meeting (AGM) of the Company held on July 27, 2011, inter alia, have accorded to the following: 1. Adoption of the Audited Balance Sheet of the Company as at March 31, 2011 and Profit and Loss account and Cash Flow Statement for the year ended on that date together with Notes and schedules (Standalone & Consolidated) and the Reports of the Auditors & Directors. 2. Declaration of Dividend @ Rs 3/- per equity share on fully paid-up equity shares of Rs 2/- each, absorbing a sum of Rs 1,556,094,682/- (inclusive of tax on dividend Rs 217,201,885/-) for the year ended March 31, 2011. 3. Re-appointment of Mr. Nilesh Gupta & Dr K U Mada, as Directors of the Company. 5. Re-appointment of M/s. Deloitte Haskins & Sells, Chartered Accountants, as Statutory Auditors, to hold office from the conclusion of this Annual General Meeting till the conclusion of the next Annual General Meeting. (As Per BSE Announcement Dated on 10.08.2011) 
28-Jul-10
Lupin Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 21, 2010 to July 28, 2010 (both days inclusive) for the purpose of 28th Annual General Meeting (AGM) of the Company to be held on July 28, 2010. Lupin Ltd has informed BSE that the members at the 28th Annual General Meeting (AGM) of the Company held on July 28, 2010, inter alia, have passed resolution to sub-divide 100,000,000 Equity Shares of the Company of face value of Rs. 10/- each into 500,000,000 Equity Shares of face value of Rs. 2/- each. (As Per BSE Announcement Website dated on 30.07.2010) Lupin Ltd has informed BSE that the members at the 28th Annual General Meeting (AGM) of the Company held on July 28, 2010, inter alia, have accorded to the following: 1. Adoption of the Audited Balance Sheet of the Company as at March 31, 2010, Profit & Loss Account and Cash Flow Statement for the year ended on that date, together with notes and Schedules annexed thereto (Standalone and Consolidated) and the reports of the Directors and Auditors. 2. Declaration of dividend @ Rs. 13.50 per share on 89,093,810 fully paid-up equity shares of Rs.10/- each, absorbing a sum of Rs. 1,402,530,907/- (inclusive of tax on dividend Rs. 199,764,472/-), be and is hereby declared for the year ended March 31,2010. 3. Re-appointment of Dr. Kamal K. Sharma, Mr. D. K. Contractor as Director of the Company. 4. Re-appointment of M/s. Deloitte Haskins & Sells, Chartered Accountants, as Statutory Auditors, to hold office from the conclusion of this Annual General Meeting till the conclusion of the next Annual General Meeting. 5. Appointment of Mr. K. V. Kamath, Dr. Vijay Kelkar & Mr. Richard Zahn, as Director of the Company. 6. Consent accorded of the members of the Company for Sub-division of the 100,000,000 Equity shares of the face value of Rs.10/- each in the Authorised Share Capital of the Company into 500,000,000 Equity shares of the face value of Rs. 2/- each, and consequential amendments in the Memorandum of Association of the Company, subject to necessary provisions & approvals. (As Per BSE Announcement Dated on 31.08.2010) 
29-Jul-09
Lupin Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 22, 2009 to July 29, 2009 (both days inclusive) for the purpose of 27th Annual General Meeting (AGM) of the Company to be held on July 29, 2009. Lupin Ltd has informed BSE that the members at the 27th Annual General Meeting (AGM) of the Company held on July 29, 2009, inter alia, have accorded to the following: 1. Adoption of the audited Balance Sheet of the Company as of March 31, 2009, Profit & Loss Account and Cash Flow Statement for the year ended as on that date together with notes and Schedules annexed thereto and reports of the Directors and Auditors. 2. Declaration of dividend @ Rs 12.50/- per share on 83,682,343 fully paid-up shares of Rs 10/- each, absorbing a sum of Rs 1,223,801,966/- (inclusive of tax on dividend of Rs 177,772,678/-) for the year ended March 31, 2009. 3. Re-appointment of Mr. Sunil Nair & Mr. Vinita Gupta as Directors of the Company. 4. Re-appointment of Deloitte Has0kins & Sells, Chartered Accountants, as the Statutory Auditors to hold office from the conclusion of this Annual General Meeting till the conclusion of the next Annual General Meeting on the remuneration, terms and conditions. 5. Appointment of Mr. Nilesh Gupta as Director of the Company. 6. Alternation in the Articles of Association of the Company. 7. Authority to the Board for mortgaging and / or charging by the Board of Directors ('the Board' which term shall include any Committee thereof for the time being exercising the powers conferred on the Board by this resolution) of all the immovable and / or movable properties of the Company, wheresoever situate, both present and future and / or the whole or substantially the whole of the undertaking(s) of the Company to or in favour of any public or private financial institutions, banks, mutual funds, bodies corporate or any other person whomsoever participating in extending financial assistance, to secure any term loans, working capital facilities, debentures or any other type of financial assistance, not exceeding Rs 5000 million (Rupees five thousand million only) lent and advanced / to be lent and advanced by them, together with interest, compound interest, additional interest, liquidated damages, premia on prepayment or on redemption, costs, charges or expenses or monies payable by the Company to them under loan agreements / letters of sanction / debenture trust deed, etc. (As Per BSE Announcement Website dated on 25.08.2009) 
22-Jul-08
Lupin Ltd has informed BSE that the 26th Annual General Meeting (AGM) of the Company will be held on July 22, 2008. 

EGM

05-Dec-03
EGM 05/12/2003 To alter AOA of the company, Increase the limit of investment by FII in the company's equity capital to 33%, introduction of an ESOP not exceeding 1% of the paid up share capital of the company, amounting to 4,01,411 equity shares of the face value of Rs.10/- in the company and to delist the equity shares of the company from Ahmedabad, Delhi, Jaipur and Kolkata Stock Exchanges. The Company has informed that at the EGM held on 05.12.2003, the shareholders have passed the following resolutions: 1) Alterations of certain clauses of the AoA 2)Enhancing the limit of investment by FIIs to 33% of the paid up share capital of the Company 3)An in principle approval for the issue of not exceeding 401411 Equity shares of Rs 10 each under ESOP 4)To delist the equity shares of the Company from the Stock Exchanges at Ahmedabad, Delhi, Jaipur and Kolkatta 5)Appointed Mr Marc Desaedeleer and Mr Sunil Nair were appointed as Additional Directors who were nominated by Citicorp Banking Corporation, Baharin and Citicorp International Finance Corporation, USA respectively 6)As part of the internal restructuring of the promoters' shareholdings in the Company 5037713 Equity Shares of Rs 10 each are proposed to be sold by promoters to Citigroup Banking Corporation, Baharin and Citicorp International Finance Corporation, USA. In terms of the Share Purchase Agreement and the Escrow Agreement, the abovementioned shares as well as the purchase consideration have been deposited with Escrow Agent Further the Company has informed that its Investigational New Drug Application (INDA)for the prophylactic treatment of migrane has been approved by the IND Sub Committee of the Indian Council of Medical Research Lupin plans to initiate Phase 1 clinical trials in India . (As per BSE Bulletin dated on 06/12/2003) Lupin Limited has informed the Exchange that at the EGM of the Company held on December 05, 2003, the members of the Company have by means of a special resolution determined to delist shares of the Company, from the following exchanges : 1) The Calcutta Stock Exchange Association Ltd. 2) The Stock Exchange, Ahmedabad, 3) Jaipur Stock Exchange Ltd., 4) The Delhi Stock Exchange Association Ltd. The Company has initiated actionto secure de-listing of the equity shares of the Company, from the aforesaid exchanges. The Equity shares of the Company are listed on the NSE and BSE and will continue to be listed and traded on NSE and BSE. (As per NSE Bulletin dated on 27/01/2004) Lupin Limited has informed the Exchange that at its EGM held on December 05, 2003 the shareholders had passed a special resolution for voluntary delisting of Company's equity shares from stock exchanges at Ahmedabad, Delhi, Jaipur and Kolkata. The company has received approval for delisting of its shares from the Kolkata Stock Exchange. (AS per NSE BUlletin dated on 20/10/2004) 

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Lupin 34,417.57 27.30 7.10 21.23 23.4 22.7 0.30
Divi's Lab. 13,374.56 21.87 5.24 13.41 27.3 34.1 0.02
Jubilant Life 2,431.71 30.90 1.31 21.18 3.1 6.4 1.43
Shilpa Medicare 747.01 14.92 2.56 9.34 16.3 18.0 0.19
Hikal 679.47 26.63 1.98 5.65 22.4 18.2 1.53
Elder Pharma 596.28 6.48 0.77 6.59 12.9 13.0 1.25
Dishman Pharma. 577.41 11.93 0.86 5.44 6.8 10.2 0.80
Vinati Organics 550.01 8.01 2.28 5.63 33.2 31.3 0.75
Shasun Pharma. 456.20 16.55 1.68 7.48 14.0 8.9 1.05
Orchid Chemicals 436.79 0.00 0.48 7.67 9.7 8.3 1.75
Nectar Lifesci. 375.48 4.38 0.43 6.25 9.7 11.2 1.22
Sequent Scien. 340.05 0.00 2.23 7.62 -3.9 5.9 1.58
Suven Life Scie. 304.26 9.87 1.97 10.21 11.3 9.1 0.64
Granules India 278.50 9.23 1.03 4.12 11.7 15.2 0.57
Aarti Drugs 266.54 5.85 1.28 4.78 13.5 13.7 1.48

Futures & Options Quote

 
Expiry Date
772.05 1.05  (0.1%)
Instrument: FUTSTK
Expiry Date: 30 May 2013
Open Price: 765.85
Average Price: 777.08
No. of Contracts Traded: 1,209,500
Open Interest: 2,503,500
Underlying: LUPIN
Market Lot: 500
Previous Close: 772.05
Day’s High | Low: 788.05 | 765.50
Turnover (Cr.): 93.99
Open Int. Change: -28,000.00 ( [1.1]% )
View detailed F& O quotes >>

Key Information

Key Executives:

Desh Bandhu Gupta , Chairman  

Kamal K Sharma , Managing Director  

M D Gupta , Executive Director  

Nilesh Gupta , Executive Director  


Company Head Office / Quarters:
159 C S T Road,
Kalina Santacruz (East),
Mumbai,
Maharashtra-400098
Phone : 91-22-66402323
Fax : 91-22-26528806
E-mail : info@lupinworld.com
Web : http://www.lupinworld.com
Registrars:
Lupin Ltd
Investors Serv Dept
159 C S T Road
Kalina Santa Cruz(E)
Mumbai - 400 098

Fund Holding


Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Closing : Just Dial
Economic Events
list Foreign Buying Japan Bonds (Yen)
list Japan Buying Foreign Bonds (Yen)
Results
list Larsen & Toubro | Zee Entertainmen | Thermax